Pnuvax: PnuVax lands $29m grant for pneumonia vaccine

PnuVax said this week that it landed a $29.4 million grant from the Bill & Melinda Gates Foundation to develop and test its pneumococcal conjugate vaccine. The company is slated to receive milestone payments over the next three years as its vaccine moves through development and into proof-of-concept clinical trials. PnuVax's product is designed to [...]The post PnuVax lands $29m grant for pneumonia vaccine appeared first on Drug Delivery Business.